Catatonia and Glucose-6-Phosphate Dehydrogenase Deficiency: A Report of Two Cases and a Review

Psychosomatics

Volumn 55, Issue 1, 2014, Pages 92-97

  Raj, Vidya ^a   Chism, Keira ^b   Minckler, Michael R ^c   Denysenko, Lex ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMINOTRANSFERASE; ANTISTREPTOLYSIN; AZITHROMYCIN; BENZATROPINE; CANNABINOID; CLONAZEPAM; DOXYCYCLINE; ETIRACETAM; GANCICLOVIR; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN; LITHIUM; LORAZEPAM; MEROPENEM; OLANZAPINE; PREDNISONE; SERTRALINE; SIMVASTATIN; TIOTIXENE; VALPROATE SEMISODIUM; VALPROIC ACID; VANCOMYCIN;

ADULT; AFRICAN AMERICAN; ALERTNESS; ARTICLE; ASSISTED LIVING FACILITY; ASTHMA; BEDTIME DOSAGE; BEHAVIOR CHANGE; BIPOLAR DISORDER; BONE MARROW BIOPSY; BUSH FRANCIS CATATONIA RATING SCALE; CASE REPORT; CATATONIA; CLONUS; COMPUTER ASSISTED TOMOGRAPHY; DEFENSE MECHANISM; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG URINE LEVEL; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEVER; GENETIC ANALYSIS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HAND TREMOR; HEMOGLOBIN BLOOD LEVEL; HEMOLYTIC ANEMIA; HUMAN; HYPERLIPIDEMIA; HYPERREFLEXIA; HYPERTENSION; IMMOBILITY; LOGORRHEA; MALAISE; MALE; MASTICATION; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NEUROLEPTIC MALIGNANT SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; ORIENTATION; PATHOPHYSIOLOGY; PSYCHOMOTOR RETARDATION; RATING SCALE; RESTLESSNESS; SCHIZOPHRENIA; SORE THROAT; STREPTOCOCCAL PHARYNGITIS; STUTTERING; THOUGHT DISORDER; TREATMENT DURATION; TREMOR; UNSPECIFIED SIDE EFFECT; YOUNG ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; COMPLICATION; CONSCIOUSNESS DISORDERS; SYNDROME;

ADULT; AUTONOMIC NERVOUS SYSTEM DISEASES; CATATONIA; CONSCIOUSNESS DISORDERS; FEVER; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HUMANS; MALE; SYNDROME; YOUNG ADULT;

EID: 84891371343     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.06.011     Document Type: Article

References (21)

1. Nkhoma E.T., Poole C., Vannappagari V., Hall S.A., Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009, 42(3):267-278.
2. Chinevere T.D., Murray C.K., Grant E, Johnson G.A., Duelm F., Hospenthal D.R. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med 2006, 171(9):905.
3. Luzzatto L Glucose-6-phosphate dehydrogenase deficiency: from genotype to phenotype. Haematologica 2006, 91(10):1303-1306.
4. Caroff SN, Mann SC, Francis A, Fricchione GL (eds) Catatonia: from psychopathology to neurobiology. Washington, D.C., American Psychiatric Publishing, Inc, 2004, pp 106-109.
5. Dern R.J., Glynn M.F., Brewer G.J. Studies on the correlation of the genetically determined trait G-6-P-D deficiency with behavioral manifestations of schizophrenia. J Lab Clin Med 1963, 62:319.
6. Fieve R.R., Brauninger G., Fleiss J., Cohen G. Glucose-6-phosphate dehydrogenase deficiency and schizophrenic behavior. J Psychiatr Res 1965, 3:255-262.
7. Mendlewicz J., Linkowski P., Wilmotte J. Linkage between glucose-6-phosphate dehydrogenase deficiency and manic-depressive psychosis. Br J Psychiatry 1980, 137:337-342.
8. Baron M. X-linkage and manic depressive illness: a reassessment. Soc Biol 1991, 38:179-188.
9. Carcassi U.E. The interaction between beta-thalassemia, G-6-PD deficiency, and favism. Ann NY Acad Sci 1974, 232:297-305.
10. Bocchetta A., Piccardi M.P., Del Zompo M. Is bipolar disorder linked to Xp28?. Nat Genet 1994, 6:224.
11. Raffa M., Barhoumi S., Atiq F., Fendri C., Kerkeni A., Mechri A. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder. Prog Neuropsychopharmacol Biol Psychiatry 2012, 39(2):371-375.
12. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord 2008, 111:135-144.
13. Uma Devi P., Chinnaswamy P. Oxidative injury and enzymatic antioxidant misbalance in schizophrenics with positive, negative and cognitive symptoms. Afr J Biochem Res 2008, 2(4):92-97.
14. Bocchetta A. Psychotic mania in glucose-6-phosphate-dehydrogenase-deficient subjects. Ann Gen Hosp Psychiatry 2003, 2(1):6. 10.1186/1475-2832-2-6.
15. Malhi G.S., Tanious M., Das Pritha, Coulston C.M., Berk M. Potential mechanisms of action of lithium in bipolar disorder. CNS Drugs 2013, 27:135-153.
16. Obregon D.F., Velasco R.M., Wuerz T.P., Catalano M.C., Catalano G., Kahn D. Memantine and catatonia: a case report and literature review. J Psychiatr Pract 2011, 17:292-299.
17. Khairova R., Pawar R., Salvadore G., et al. Effects of lithium on oxidative stress parameters in healthy subjects. Mol Med Rep 2012, 5(3):680-682.
18. Berk M., Copolov D.L., Dean O., et al. N-acetyl cysteine for depressive symptoms in bipolar disorder-a double-blind randomized placebo-controlled trial. Biol Psychiatry 2008, 64:468-475.
19. Berk M., Copolov D., Dean O., et al. N-acetyl cysteine as a glutathione precursor for schizophrenia-a double-blind, randomized, placebo-controlled trial. Biol Psychiatry 2008, 64:361-368.
20. Berk M., Malhi G.S., Gray L.J., Dean O.M. The promise of N-acetylcysteine in neuropsychiatry. Trends Pharmacol Sci 2013, 34(3):167-177.
21. Perera J., Tan J.H., Jeevathayaparan S., Chakravarthi S., Haleagrahara N. Neuroprotective effects of alpha lipoic acid on haloperidol-induced oxidative stress in the rat brain. Cell Biosci 2011, 1:12. 10.1186/2045-3701-1-12.